Showing 1 - 10 of 39
Background: Non-adherence to antihypertensive drugs is high, and the economic consequences of non-adherence may be substantial. The Medication Events Monitoring System (MEMS), which is a method to improve adherence, has been shown to be a useful tool for the management of adherence problems....
Persistent link: https://www.econbiz.de/10005449177
Objective The objective of the present study was to compare the SF-6D and EQ-5D dimension scores and utilities of patients with hypertension, ankylosing spondylitis, panic disorder and osteoarthritis. Methods The data set was taken from four separate studies (867 cases). Both the EuroQol and the...
Persistent link: https://www.econbiz.de/10014049960
Persistent link: https://www.econbiz.de/10001067986
Persistent link: https://www.econbiz.de/10000787585
Persistent link: https://www.econbiz.de/10010496314
Persistent link: https://www.econbiz.de/10011868954
Productivity costs related to paid work are commonly calculated in economic evaluations of health technologies by multiplying the relevant number of work days lost with a wage rate estimate. It has been argued that actual productivity costs may either be lower or higher than current estimates...
Persistent link: https://www.econbiz.de/10010930770
Objective: Markov models are increasingly used in economic evaluations of (new) treatments for chronic diseases. In this study we propose a Markov model with health states defined by the disease activity score (DAS) to be used to extrapolate efficacy data from short-term clinical trials in...
Persistent link: https://www.econbiz.de/10005243092
Background: Smoking cessation should be encouraged in order to increase life expectancy and reduce smoking-related healthcare costs. Results of a randomised trial suggested that reimbursing the costs of smoking cessation treatment (SCT) may lead to an increased use of SCT and an increased number...
Persistent link: https://www.econbiz.de/10005243095
In economic evaluation of healthcare programmes both QOL and productivity of patients are aspects to be studied. Normally, the former is part of the measurement of the effectiveness of the programme and the latter is part of the measurement of its costs. In this paper we highlight the...
Persistent link: https://www.econbiz.de/10005243161